Zydus Life Gets USFDA Nod for Eluxadoline Tablets, Shares Up 1.5% – Equitypandit
March 17, 2025March 17, 2025 Shares of Zydus Lifesciences Ltd rose 1.5% to touch a day’s high of Rs 901.30 on 17th March after the firm announced that it had received final approval from the US Food and Drug Administration (USFDA) to manufacture Eluxadoline Tablets,…